Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis. - Wikidata - awgldk - TriplyDB

Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.

Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.

http://www.wikidata.org/entity/Q43004059

about

Infection as an Environmental Trigger of Multiple Sclerosis Disease Exacerbation Infectious Mononucleosis Intrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatments Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy Primary Progressive Multiple Sclerosis: Putting Together the Puzzle FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination.Epstein-barr virus vaccines.Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.The Role of Latently Infected B Cells in CNS Autoimmunity.Acute disseminated encephalomyelitis progressing to multiple sclerosis: are infectious triggers involved?Designing an effective vaccine to prevent Epstein-Barr virus-associated diseases: challenges and opportunities.Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis.Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis.Tolerance of activated pathogenic CD4+ T cells by transcriptional targeting of dendritic cells.Beta and Gamma Human Herpesviruses: Agonistic and Antagonistic Interactions with the Host Immune System.New advances in CNS immunity against viral infection.

P2860

Q26779416-7ED71FA0-C322-4C55-9477-6FDC98B067CA Q26783692-B4E40115-B062-40D5-A83E-C2FFEC7A807E Q26851694-262AC22E-66C2-4579-9FD2-D8F035A7A749 Q30878158-70B0F3E8-3998-4079-BC90-2821285B943C Q33365606-CC9F97DD-2229-46B5-A0A1-7F584598675A Q34105944-21491F1F-0AE9-4DF8-94E3-98344B7DA036 Q35053650-028D3D1C-BAC8-4015-8130-2B5C55D35AB7 Q35915780-AA94A75C-2889-41E1-9FCD-2ABBF3E9A426 Q36216025-765723FF-A50C-4E44-96E5-27442A777986 Q38199387-2DB0C7DC-7330-4DFC-8884-A215DB49D7F0 Q39170011-E96EB646-BE0B-40AA-9228-5DDF0FFCB07E Q39279957-6AB71935-40C8-4F55-8D69-D3DE82451B49 Q40333194-820E7C66-4E1F-4D82-AFA4-0B8C273CCA43 Q42157420-1E6EF0E5-3422-4038-9D49-6A62F976EB1D Q47550811-00788FD1-DAE6-4AAA-9ACA-9CF063A155F0 Q47559442-E7229011-9882-40B7-B2C4-26CC25992436

P2860

Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.

http://www.wikidata.org/entity/Q43004059

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.

@en

Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.

@nl

type

label

Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.

@en

Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.

@nl

prefLabel

Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.

@en

Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.

@nl

P1433

Q43004059-6A749740-4E59-4491-943F-82DEE585ECAD

P1476

Q43004059-B6C0B899-1538-4F28-9D2A-E38A52D00724

P2093

Q43004059-30917B5A-F52C-4BA5-A688-60FA6326D3C0

Q43004059-36590D91-0703-4BDB-85BA-CB2F92F16828

Q43004059-552E0FD2-47CB-4565-BD52-772C861EC379

Q43004059-5C9F3219-9383-44D4-8B2D-E4DCF272BE7D

Q43004059-DBFCBE09-633B-4729-8E87-4F7477107328

P2860

Q43004059-1FBA3D83-C94A-446D-B44E-13A2E5AA64D4

Q43004059-5F76D8FE-CFD7-43A9-BD1D-838E9C7D1E33

Q43004059-64B26220-7912-4ABE-959E-3FF8E1D8319D

Q43004059-6EF6E421-F66E-41B1-8016-73336D50958E

Q43004059-7596307A-F99B-4E62-8AFE-BC053B503AE2

Q43004059-80FAF2E6-E2F8-4358-9C48-AAF9E4CE2F94

Q43004059-A102A8BA-58F3-4D1E-ABC6-57C094A3B18C

Q43004059-AFC11A3D-88FB-4109-89E5-4BF10B38D06A

Q43004059-B6E3D866-E7F8-49F7-A9A1-A541404F93F8

Q43004059-BE7A7B34-D7BB-4C32-9781-B0536659A384

P304

Q43004059-DE1A0A51-B3F1-4609-B4C8-F6874FA1E084

P31

Q43004059-7e672d8a-edce-4f9c-8ec6-3044455d7162

Q43004059-AD8B686D-ACF2-40D5-9DA5-B8E741A50651

P356

Q43004059-4DC411DF-4500-4880-ACCA-F9197DD243FC

P433

Q43004059-5CF7A837-90D3-451A-A522-CE4D1489FD64

P478

Q43004059-A125F6B3-426A-43E7-A7A4-126B70B6721C

P50

Q43004059-179491FC-4C2C-466D-95A3-CB2A2A19776F

Q43004059-26A8D5CF-5795-4867-92BE-633E8281C0E3

Q43004059-47416257-614B-4274-AF52-AA9A61BBDDE5

Q43004059-9DAEB1D4-658B-4D76-9ACA-8A63A8B645E4

P577

Q43004059-7422A4FF-E429-4A78-967A-051F61CEF13E

P5875

Q43004059-572DDBEB-6A1F-4A08-A9E4-A953C801D036

P698

Q43004059-C01B9B53-1044-45A9-B4B2-63D4312439FB

P921

Q43004059-D61021F1-7380-4C7A-A145-AF35471AB3CF

Q43004059-F0AC3603-0B82-4428-B845-18E693D13F6C

P932

Q43004059-DB6A6331-FB90-46AB-967A-1832AC8D6535

P356

1352458514521888

P1433

Multiple Sclerosis Journal

P1476

Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.

@en

P2093

Corey Smith

http://www.w3.org/2001/XMLSchema#string

Kaye D Hooper

http://www.w3.org/2001/XMLSchema#string

Leone Beagley

http://www.w3.org/2001/XMLSchema#string

Meenakshi Raj

http://www.w3.org/2001/XMLSchema#string

Michael P Pender

http://www.w3.org/2001/XMLSchema#string

P2860

Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation.

Decreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes.

Epstein-barr virus infection and multiple sclerosis: a review.

Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases.

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain

Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis.

The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis

Effective treatment of metastatic forms of Epstein-Barr virus-associated nasopharyngeal carcinoma with a novel adenovirus-based adoptive immunotherapy.

Association of innate immune activation with latent Epstein-Barr virus in active MS lesions.

Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system.

P304

1541-1544

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1352458514521888

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Peter A. Csurhes

Scott R Burrows

P577

2014-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260091189

http://www.w3.org/2001/XMLSchema#string

P698

24493474

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

4230458

http://www.w3.org/2001/XMLSchema#string